Explore the full ebook collection and download it now at textbookfull.
com
Addiction medicine 2nd Edition John B. Saunders Et
                       Al.
  https://textbookfull.com/product/addiction-medicine-2nd-
                edition-john-b-saunders-et-al/
                            OR CLICK HERE
                           DOWLOAD EBOOK
  Browse and Get More Ebook Downloads Instantly at https://textbookfull.com
       Click here to visit textbookfull.com and download textbook now
          Your digital treasures (PDF, ePub, MOBI) await
         Download instantly and pick your perfect format...
                   Read anywhere, anytime, on any device!
Management John R. Schermerhorn Et Al.
https://textbookfull.com/product/management-john-r-schermerhorn-et-al/
textbookfull.com
Financial Accounting John Hoggett Et Al.
https://textbookfull.com/product/financial-accounting-john-hoggett-et-
al/
textbookfull.com
Pain Medicine Board Review Anna Woodbury Et Al.
https://textbookfull.com/product/pain-medicine-board-review-anna-
woodbury-et-al/
textbookfull.com
Auerbach’s Wilderness Medicine Paul S. Auerbach Et Al.
https://textbookfull.com/product/auerbachs-wilderness-medicine-paul-s-
auerbach-et-al/
textbookfull.com
Gabbe’s Obstetrics Essentials: Normal & Problem
Pregnancies Mark B Landon Et Al.
https://textbookfull.com/product/gabbes-obstetrics-essentials-normal-
problem-pregnancies-mark-b-landon-et-al/
textbookfull.com
Ballistic Trauma A Practical Guide 4th Edition John Breeze
Et Al. (Eds.)
https://textbookfull.com/product/ballistic-trauma-a-practical-
guide-4th-edition-john-breeze-et-al-eds/
textbookfull.com
Evidence Based Medicine How to Practice and Teach EBM
Sharon E. Straus Et Al.
https://textbookfull.com/product/evidence-based-medicine-how-to-
practice-and-teach-ebm-sharon-e-straus-et-al/
textbookfull.com
Harrison’s principles of internal medicine: self-
assessment and board review 19th Edition Charles Wiener Et
Al.
https://textbookfull.com/product/harrisons-principles-of-internal-
medicine-self-assessment-and-board-review-19th-edition-charles-wiener-
et-al/
textbookfull.com
Harrison's Principles of Internal Medicine, Twentieth
Edition (Vol.1 & Vol.2) J. Larry Jameson Et Al.
https://textbookfull.com/product/harrisons-principles-of-internal-
medicine-twentieth-edition-vol-1-vol-2-j-larry-jameson-et-al/
textbookfull.com
OXFORD MEDICAL PUBLICATIONS
Addiction Medicine
Oxford Specialist Handbooks published and forthcoming
General Oxford Specialist                 Parkinson’s Disease and Other Movement
   Handbooks                                 Disorders, 2e
A Resuscitation Room Guide                Stroke Medicine, 2e
Day Case Surgery
Perioperative Medicine, 2e                Oxford Specialist Handbooks
Pharmaceutical Medicine                      in Oncology
Postoperative Complications, 2e           Practical Management of Complex Cancer
                                             Pain
Oxford Specialist Handbooks in
  Accident & Emergency Medicine           Oxford Specialist Handbooks
Retrieval Medicine                          in Paediatrics
Oxford Specialist Handbooks               Paediatric Dermatology
  in Anaesthesia                          Paediatric Endocrinology and Diabetes
                                          Paediatric Gastroenterology, Hepatology,
Anaesthesia for Medical and Surgical        and Nutrition
  Emergencies                             Paediatric Haematology and Oncology
Cardiac Anaesthesia                       Paediatric Intensive Care
Neuroanaesthesia                          Paediatric Nephrology, 2e
Obstetric Anaesthesia                     Paediatric Neurology, 2e
Ophthalmic Anaesthesia                    Paediatric Palliative Medicine, 2e
Paediatric Anaesthesia                    Paediatric Radiology
Regional Anaesthesia, Stimulation         Paediatric Respiratory Medicine
  and Ultrasound Techniques               Paediatric Rheumatology
Thoracic Anaesthesia
Oxford Specialist Handbooks               Oxford Specialist Handbooks
   in Cardiology                             in Pain Medicine
Adult Congenital Heart Disease            Spinal Interventions in Pain Management
Cardiac Catheterization and Coronary      Oxford Specialist Handbooks
   Intervention
                                             in Psychiatry
Cardiac Electrophysiology and Catheter
   Ablation                               Addiction Medicine, 2e
Cardiovascular Computed Tomography        Child and Adolescent Psychiatry
Cardiovascular Magnetic Resonance         Forensic Psychiatry
Echocardiography, 2e                      Medical Psychotherapy
Fetal Cardiology                          Old Age Psychiatry
Heart Failure, 2e                         Oxford Specialist Handbooks
Hypertension                                 in Radiology
Inherited Cardiac Disease
Nuclear Cardiology                        Interventional Radiology
Pacemakers and ICDs                       Musculoskeletal Imaging
Pulmonary Hypertension                    Pulmonary Imaging
Valvular Heart Disease                    Thoracic Imaging
Oxford Specialist Handbooks               Oxford Specialist Handbooks
  in Critical Care                           in Surgery
Advanced Respiratory Critical Care        Cardiothoracic Surgery, 2e
Cardiothoracic Critical Care              Colorectal Surgery
                                          Gastric and Oesophageal Surgery
Oxford Specialist Handbooks               Hand Surgery
  in End of Life Care                     Hepatopancreatobiliary Surgery
End of Life Care in Cardiology            Neurosurgery
End of Life Care in Dementia              Operative Surgery, 2e
End of Life Care in Nephrology            Oral and Maxillofacial Surgery, 2e
End of Life Care in Respiratory Disease   Otolaryngology and Head and Neck
End of Life in the Intensive Care Unit       Surgery
                                          Paediatric Surgery
Oxford Specialist Handbooks               Plastic and Reconstructive Surgery
   in Infectious Disease                  Renal Transplantation
Infectious Disease Epidemiology           Surgical Oncology
                                          Urological Surgery
Oxford Specialist Handbooks               Vascular Surgery, 2e
  in Neurology
Epilepsy
                  Oxford Specialist
                  Handbooks
                  Addiction
                  Medicine
                  Second Edition
                  Edited by
John B. Saunders                            E. Jane Marshall
Professor and Consultant Physician in       Consultant Psychiatrist, Alcohol Service,
Internal Medicine and Addiction Medicine,   South London and Maudsley National
University of Queensland, University of     Health Service Trust and the National
Sydney, and St. John of God Health Care,    Addiction Centre, Institute of Psychiatry,
Wesley Health Care, and South Pacific       King’s College London, UK
Private Hospital, Sydney, Australia
                                            Walter Ling
Katherine M. Conigrave                      Integrated Substance Abuse Program
Professor in Addiction Medicine and         (ISAP), School of Medicine, University
Public Health, Sydney Medical School,       of California at Los Angeles (UCLA),
University of Sydney, and Addiction         and formerly Commissioner for
Specialist Royal Prince Alfred Hospital,    Narcotics and Dangerous Drugs
Sydney, Australia                           Commission, Los Angeles, CA, USA
Noeline C. Latt                             Susumu Higuchi
Addiction Medicine Specialist, Royal        Director, National Hospital
North Shore Hospital, and Sydney Medical    Organization Kurihama Medical and
School, University of Sydney, Australia     Addiction Center and Director of the
                                            World Health Organization (WHO)
David J. Nutt                               Collaborating Centre on Research and
                                            Training of Alcohol-Related Problems,
Professor of Psychopharmacology,
                                            Kanagawa, Japan
Division of Brain Science, Department
of Medicine, Hammersmith Hospital,
Imperial College London, UK, and
Founding Chair of DrugScience, UK
With a Foreword by Karl Mann
                  1
1
Great Clarendon Street, Oxford, OX2 6DP,
United Kingdom
Oxford University Press is a department of the University of Oxford.
It furthers the University’s objective of excellence in research, scholarship,
and education by publishing worldwide. Oxford is a registered trade mark of
Oxford University Press in the UK and in certain other countries
© Oxford University Press 2016
The moral rights of the authorshave been asserted
First Edition published 2009
First Edition, revised and updated 2011
Second Edition published 2016
Impression: 1
All rights reserved. No part of this publication may be reproduced, stored in
a retrieval system, or transmitted, in any form or by any means, without the
prior permission in writing of Oxford University Press, or as expressly permitted
by law, by licence or under terms agreed with the appropriate reprographics
rights organization. Enquiries concerning reproduction outside the scope of the
above should be sent to the Rights Department, Oxford University Press, at the
address above
You must not circulate this work in any other form
and you must impose this same condition on any acquirer
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America
British Library Cataloguing in Publication Data
Data available
Library of Congress Control Number: 2015955010
ISBN 978–0–19–871475–0
Printed and bound in China by
C&C Offset Printing Co. Ltd
Oxford University Press makes no representation, express or implied, that the
drug dosages in this book are correct. Readers must therefore always check
the product information and clinical procedures with the most up-to-date
published product information and data sheets provided by the manufacturers
and the most recent codes of conduct and safety regulations. The authors and
the publishers do not accept responsibility or legal liability for any errors in the
text or for the misuse or misapplication of material in this work. Except where
otherwise stated, drug dosages and recommendations are for the non-pregnant
adult who is not breast-feeding
Links to third party websites are provided by Oxford in good faith and
for information only. Oxford disclaims any responsibility for the materials
contained in any third party website referenced in this work.
                                                                                 v
         Preface
Origin of this handbook
This Oxford Specialist Handbook Addiction Medicine is the result of many
years, preparation by a group of colleagues who have been clinicians, teach-
ers, and researchers in the addictive disorders field for many years. The
present edition replaces the first edition, which was published in 2009. That
had its origins in a series of lecture notes produced for the University of
Sydney more than 30 years ago and clinical protocols developed separately
and in collaboration by the authors and constantly updated over this time.
   The scope of the second edition has been expanded in several ways. It
now includes the behavioural addictions such as gambling and gaming and
includes a broader range of psychoactive substances. It aims to be interna-
tional in scope. The editors are drawn from the United Kingdom, Australia,
United States of America, and Japan and there are contributing authors
from 25 countries worldwide.
   Our aim continues to be to offer a contemporary, broadly based, and
clinically grounded text that summarizes the scientific basis and the practice
of addiction medicine.
Evidence and practice
Evidence-based practice continues to increase in impact and there is an
expectation that the approaches made in management of addictive disor-
ders and the selection of medications, therapies, and overall strategy are
based on scientific data from controlled clinical trials and other relevant
studies. This applies in addiction medicine as much as it does in any other
field of healthcare. We recognize, however, that as in other areas the scien-
tific evidence base is not comprehensive, particularly when a person with an
addictive disorder has different co-morbidities or when standard treatment
approaches have been exhausted, or simply where the evidence base does
not exist.
    Our approach to the second edition has been to draw upon the follow-
ing sources:
1. Current guidelines developed according to prevailing international
    standards for clinical guidelines and which include guidelines published
    by the World Health Organization, government departments of health
    and human services (e.g. from the US, UK, Australia, Japan, Germany,
    France, Sweden, and other Nordic countries) and those produced by
    relevant professional organizations, academies, and associations, which
    have been based on systematic reviews of the literature and undergone
    extensive processes of validation.
2. Publically accessible scientific evidence on the efficacy of treatment
    (with an emphasis on systematic reviews, meta-analyses, and
vi PREFACE
     randomized controlled trials), supplemented by other scientifically valid
     clinical, psychometric, and epidemiological studies.
  3. The clinical practice and experience of the authors, ensuring that the
     recommendations are appropriate to many clinical practice settings and,
     where there is an absence of evidence from scientific studies, that the
     material published here represents a distillation of practice which we
     consider to have international relevance and to be effective and safe.
  It should be emphasized that in clinical practice, decisions need to be made
  often in the absence of scientific evidence. This may be simply because
  there is none or, very typically, the clinical situation develops beyond what
  scientific evidence exists or could ever realistically be expected to exist. In
  clinical practice, the focus is on the individual (or it may be on a couple, a
  family, or a group) and individuals and groups of individuals are infinitely
  variable. Scientific data will never exist to cover the multiple variations and
  eventualities in terms of comorbid disorders, previous treatment expe-
  rience, lack of response to an approved treatment, individual patient or
  family preference, and some of the unknowns such as vital diagnostic or
  background information not being available at the time the clinical decision
  has to be made. These are the realities of the clinical life and in producing
  this handbook we recognize these as realities. Clinical practice is not merely
  the application of the evidence base to a particular person. Rather, the evi-
  dence base informs and guides clinical practice.
  Who is this book for?
  This handbook is intended as a concise and practical guide for students and
  practitioners of medicine, nursing, psychology, and other health profession-
  als whose work brings them into contact with people with addictive dis-
  orders. In particular, it is designed for students and post-graduate trainees
  and fellows in addiction medicine, internal medicine, psychiatry, emergency
  medicine, pain management, gastroenterology, and general medical (fam-
  ily physician) practice. We believe it will be useful and relevant to nurses,
  particularly those working as specialists in addictive disorders, clinical psy-
  chologists, psychologists and counsellors, and social workers and for staff in
  specialist multidisciplinary agencies which provide help, support, and treat-
  ment for people with addictive disorders.
  Why is this book important?
  Alcohol and other substance use rank among the five top risk factors con-
  tributing to the global burden of disease. In recent years, there has been a
  rapid increase in non-substance forms of addiction such as gambling, inter-
  net gaming, and various other behavioural or ‘process’ addictions. In Asia
  and several other parts of the world, these latter disorders represent the
  biggest burden of ill health and social problems of any of the addictions.
  Substance use disorders can cause, mimic, underlie, or complicate a large
  number of medical and psychiatric conditions. All addictive disorders can
                                                                    PREFACE        vii
cause immense personal suffering as well as harm and costs to families,
communities, and society as a whole. Often this is not recognized. People
with addictive disorders may be reticent about revealing their substance use
and may not see its relevance. The fact that many patients use more than
one substance, sometimes multiple substances and sometimes a substance
used in combination with a behavioural addiction, further adds to the com-
plexity. Making a correct diagnosis of an addictive disorder can greatly facili-
tate management, often avoid unnecessary tests and procedures, shorten
hospital stays, and make both the clinician’s and the patient’s life easier.
The ability to diagnose addictive disorders and initiate appropriate manage-
ment is a responsibility for all health professionals. Historically, however,
most have not been confident in their ability to diagnose and manage these
disorders, as they have often been omitted from student and postgradu-
ate courses. Recent years have seen the development of a comprehen-
sive knowledge base and an understanding of the skill set and professional
practice behaviour necessary for good professional practice in this field.
Addiction medicine now has a range of approaches that compare in their
effectiveness with those in other areas of medicine.
What is covered?
This handbook provides a practical guide to the management of people with
addictive disorders. The first chapters provide important background infor-
mation and summarize the overall principles of diagnosis and management.
There follow several chapters on specific types or groups of psychoactive
substance. The nature of the substances, their pharmacological properties,
and the clinical syndromes that result are described, together with specific
guidance on diagnosis and management which takes into account both their
generic addictive properties and their specific pathophysiological ones. The
latter part of the book is devoted to the management of specific groups of
patients and people seen in specific settings, together with an account of
relevant medicolegal and ethical issues. Following the main text, the final
chapter comprises a series of practical tools, such as questionnaires, which
assist in systematic clinical practice.
   The handbook provides detailed guidelines on how to elicit a history
of substance use and other addictive activities, together with ways of
diagnosing the core clinical syndromes and the physical, psychiatric, and
social disorders that may flow from them. It includes practical guides to
brief intervention, management of intoxication, withdrawal management
(‘intoxication’), pharmacotherapies, and psychological therapies aimed at
relapse prevention, together with an account of support approaches and
the principles and practice of self-help.
viii
                Foreword
       Addictions are highly prevalent. They cause harm to the afflicted and their
       families and are costly to society. While the clinical symptomatology in peo-
       ple suffering from addictions is similar around the world, treatment and pre-
       vention are not. Research in recent years has provided enormous progress
       in our understanding of these disorders resulting in a multitude of new evi-
       dence-based treatments. However, most conditions remain under-served
       and treatment approaches vary substantially around the world. All of these
       facts call for an up-to-date and universal appraisal of the current situation.
       A comprehensive overview on emerging strategies would be instrumental
       in this and could help to meet the actual challenges.
          The Oxford Specialist Handbook—Addiction Medicine provides such a
       global perspective. The editors and authors are eminent researchers and
       clinicians in our field. They come from a large variety of areas such as
       Australia, Asia, Europe, and North America. While the first edition of the
       textbook in 2009 already provided a very broad view on addictions and
       ways of dealing with them, the revised version gives an update of current
       concepts and newly emanating strategies. Important extensions have been
       made providing several new chapters and incorporating new fields such as
       gambling and gaming as examples for behavioural addictions. The handbook
       now also includes evidence-based recommendations from the most recent
       clinical guidelines from around the world.
          Prof. John Saunders of Sydney and Queensland Universities and his col-
       leagues are to be congratulated for their enormous efforts. Their book
       Addiction Medicine gives the necessary detail to understand and respond to
       actual problems in an individual patient. The long standing teaching experi-
       ence of most of its authors has resulted in a text which is well structured
       and easy to read and thus offers information not only to the professional
       but also to the patient and his or her family and to others in search of some
       quick and valid information on the troublesome but also fascinating field of
       addiction.
                                                                    Karl Mann, MD
                                         Emeritus Professor of Addiction Research
                                                Central Institute of Mental Health
                                                        Medical Faculty Mannheim
                                                         University of Heidelberg
                                                                          Germany
                                                      ix
     Contents
     Acknowledgements xi
     Editors and authors xii
     Contributors xv
     Symbols and abbreviations xxiii
 1   The nature of addictive disorders	   1
 2   Epidemiology and prevention	   7
 3   Pharmacology and pathophysiology	  31
 4   The scope of intervention	  55
 5   Establishing the diagnosis	  67
 6   Acute care	  85
 7   Ongoing management of substance use disorders 103
 8   Tobacco                                           119
 9   Alcohol                                           151
10   Cannabis                                          235
11   Opioids                                           249
12   Pain and opioids                                  295
13   Benzodiazepines and the other sedative-hypnotics 307
14   Psychostimulants                                  327
15   Hallucinogens and dissociative drugs              355
16   Other drugs                                       363
17   Polysubstance use                                 391
18   Injecting drug use                                407
19   Gambling                                          427
20   Gaming                                            441
21   Other addictive disorders                         449
22   Psychiatric co-morbidity                         461
x CONTRIBUTORS
    23   Specific clinical situations                     483
    24   Special populations                              493
    25   Substance use and specific healthcare settings   545
    26   Legal and ethical issues                         563
    27   Resources                                        589
         Index 629
                                                                               xi
         Acknowledgements
In presenting this handbook to our colleagues and students, we would in
turn like to thank our own teachers. We wish to dedicate this handbook to
those who helped influence and shape our own professional careers, includ-
ing Griffith Edwards, Alex Paton, David Graham-Smith, Markku Linnoila,
Boris Tabakoff, Harding Burns, Norman Sartorius, and Harold Kalant.
   We would like to acknowledge the contribution of our colleagues in
reviewing and helping finalize parts of this book, and in particular, Robert
Batey, Glenys Dore, Anne Lingford Hughes, Martin Raw and Carina Walters.
   We would particularly like to highlight and acknowledge the key role
played by Corinne Lim, Editorial Officer, throughout the preparation of
this book.
xii
               Editors and authors
      Professor John B. Saunders MA, MB BChir, MD, FRCP, FRACP, FAChAM,
      FAFPHM is a Professor and Consultant Physician in Internal Medicine and
      Addiction Medicine, with appointments at the University of Queensland and
      University of Sydney in Australia, and with several private hospital groups.
      He graduated in pharmacology and then medicine from the University of
      Cambridge, and undertook specialist medical training in internal medicine,
      gastroenterology, and addiction medicine. His career as a clinician, service
      director, researcher, and academic in addictive disorders extends back over
      40 years, and he has extensive clinical experience in hospital and community
      settings. He has been a member of many state and federal Australian gov-
      ernment committees, including the Australian National Council on Drugs
      (2001–2007). He has worked with the World Health Organization since
      1981 and was responsible for developing the AUDIT Questionnaire. He is
      a member of the WHO’s Expert Advisory Panel on Substance Abuse and
      the ICD11 Substance-Related and Addictive Disorders Workgroup. He
      has published four books and over 330 scientific papers, reviews, and book
      chapters. He is an ISI highly cited scientist.
         Professor Katherine M. Conigrave MB BS (Hons), PhD, FAFPHM,
      FAChAM is Senior Staff Specialist in Addiction Medicine and Public Health
      Medicine at Royal Prince Alfred Hospital and Concord Hospital in Sydney,
      Australia, where she provides clinical care in out-patient, general hospi-
      tal, and residential detoxification and rehabilitation settings. She has been
      involved for many years in training medical and other health professionals
      through Sydney Medical School, University of Sydney, and through training
      sessions for practising health professionals. Professor Conigrave’s research
      has a focus on detection and early intervention for alcohol problems, and
      on improving implementation of evidence-based practice in prevention and
      treatment of substance use disorders. Over the past 15 years, Professor
      Conigrave has also worked in partnership with Aboriginal communities in
      urban, regional, and remote Australia. She has over 100 peer-reviewed
      academic publications, has received the Senior Scientist Award for the
      Australasian Professional Society for Alcohol and Other Drugs, and has
      acted as a consultant to the World Health Organization on alcohol screen-
      ing and brief intervention. She is on the Editorial Advisory Boards of Alcohol
      and Alcoholism, and of Addiction Science & Clinical Practice.
         Dr Noeline C. Latt MBBS, MPhil, MRCP, FAChAM is a Senior Staff
      Specialist in Addiction Medicine at Royal North Shore Hospital, Clinical
      Lecturer at the University of Sydney, and a Foundation Fellow of the
      Chapter of Addiction Medicine, Royal Australasian College of Physicians.
      She is a Physician and Addiction Medicine Specialist with extensive experi-
      ence in clinical pharmacology and internal medicine. After a period as a
      medical director in the Pharmaceutical Industry, she became a Specialist
      in Addiction Medicine at Westmead Hospital and as Director of the Ryde
      and Hornsby Drug & Alcohol Service she developed a drug and alcohol unit
      offering consultation liaison services and teaching programmes in alcohol
                                                  EDITORS AND AUTHORS              xiii
and substance use disorders. Her research interests have focused on plate-
let monoamine oxidase activity, and treatment of alcohol and substance use
disorders, alcoholic liver disease and hepatitis C in injecting drug users, and
substance-induced psychosis.
   Professor David J. Nutt MA, MB BChir, DM, FRCP, FRCPsych,
FMedSci is Consultant Psychiatrist and the Edmund J. Safra Professor of
Neuropsychopharmacology in the Division of Brain Science, Department
of Medicine, Hammersmith Hospital, Imperial College London. Here he
uses a range of brain imaging techniques to explore the causes of addiction
and other psychiatric disorders and to search for new treatments. He has
published over 400 original research papers, a similar number of reviews
and book chapters, eight government reports on drugs, and 28 books,
including one for the general public, Drugs: Without the Hot Air, that won the
Transmission Prize in 2014. He is currently the President of the European
Brain Council and Founding Chair of DrugScience (formerly the Independent
Scientific Committee on Drugs (ISCD)). Previously he has been president
of the British Association of Psychopharmacology, the British Neuroscience
Association, and the European College of Neuropsychopharmacology. He
broadcasts widely to the general public both on radio and television. In
2010, The Times Eureka science magazine voted him one of the 100 most
important figures in British science, and the only psychiatrist in the list. In
2013, he was awarded the John Maddox Prize from Nature/Sense about
Science for standing up for science.
   Dr E. Jane Marshall MB BCh BAO MRCP (Ireland) FRCPsych is a
Consultant Psychiatrist in Alcohol Services at the South London and
Maudsley NHS Foundation Trust and Senior Lecturer in the Addictions
at the National Addiction Centre, Institute of Psychiatry, King’s College
London. She trained in Psychiatry at St Patrick’s Hospital, Dublin, and St
Bartholomew’s and the Maudsley Hospitals in London. Her clinical work
is currently focused on a specialist out-patient and in-patient alcohol ser-
vice, and also a service for addicted healthcare professionals. She is lead
clinician for the MSc programme in Addiction at the Institute of Psychiatry.
Research interests include the evaluation of treatment for alcohol prob-
lems in specialist and generalist settings and, in particular, and treatment for
addicted healthcare professionals. Dr Marshall acts as a medical supervisor
and examiner for the General Medical Council and as a medical advisor
for the General Dental Council. Within the Royal College of Psychiatrists
she is Co-Director of Flexible Training, and a member of the executive
committee of the Faculty of the Addictions and Psychiatrists’ Support
Service Committee. Dr Marshall has contributed to national guidelines, and
has been a member of a number of Working Parties, including the Royal
College of Physicians Working Party on Alcohol in the General Hospital
(2001); an Alcohol Concern Research Forum (2002); and a Department of
Health Working Group on Alcohol-related Brain Damage (2007).
   Professor Walter Ling, MD, is Professor of Psychiatry and the Founding
Director of the Integrated Substance Abuse Programs (ISAP) at UCLA,
one of the foremost substance abuse research groups in the US. He is
board certified in neurology and psychiatry, is active in research and clinical
work, and has been listed in ‘Best Doctors in America’. Dr Ling’s research
in opiate pharmacotherapy provided pivotal information for the approval
xiv EDITORS AND AUTHORS
  of buprenorphine and naltrexone. His current focus of research includes
  abuse and dependence on methamphetamine, cocaine, heroin, and pre-
  scription opiates; opiate-induced hyperalgesia, treatment of pain in opiate-
  maintained patients, including those treated with buprenorphine, and the
  role of buprenorphine in the management of pain in these patients. Dr Ling
  is a fellow of the American Academy of Neurology; he has served as
  Commissioner for the Narcotics and Dangerous Drugs Commission, Los
  Angeles County, California; and a consultant on narcotics for the World
  Health Organization, the United Nations, and the U.S. Department of
  State. As Principal Investigator of NIDA’s Clinical Trial Network’s Pacific
  Region Node, Dr Ling has extended ISAP’s research beyond the US to
  China, Southeast Asia and the Middle East.
     Professor Susumu Higuchi, MD, PhD is Director of the National Hospital
  Organization Kurihama Medical and Addiction Center and Director of the
  World Health Organization (WHO) Collaborating Centre on Research and
  Training of Alcohol-Related Problems in Yokosuka, Japan. He has principally
  worked on genetics and clinical studies of alcohol use disorders, especially
  on the implications of genetic variations of alcohol-metabolizing enzymes
  on pharmacokinetic and pharmacodynamic effects, organ damage, and
  alcohol-use disorders. He has published more than 220 scientific papers in
  well-recognized international journals, and more than 400 papers in domes-
  tic journals. He is President of the International Society for Biomedical
  Research on Alcoholism (ISBRA), congress president in 2014, a director
  of the International Society of Addiction Medicine, and President of the
  Japanese Society of Alcohol-Related Problems. For the past decade, he has
  worked on alcohol policy and programmes, and has served as chair or a
  member of many committees of the Japanese government. He has contrib-
  uted to WHO initiatives to reduce global alcohol-related harm as a member
  of the WHO Expert Advisory Panel and a delegate of the Japanese govern-
  ment to the World Health Assembly and other WHO meetings. Clinically,
  he has been the leading psychiatrist in the field of alcohol dependence and
  behavioural addiction, especially Internet addiction in Japan.
                                                                              xv
          Contributors
Professor Peter Anderson                Dr James Bell
Professor, Substance Use                Consultant Physician, Addictions
Policy and Practice, Institute of       Clinical Academic Group, Kings
Health and Society, Newcastle           Health Partners, London, UK
University, UK                          Chapter 12: Pain and opioids
Chapter 2: Epidemiology and
prevention                              Associate Professor Renee
                                        Bittoun
Associate Professor Sawitri             Associate Professor, Sydney
Assanangkornchai                        Medical School, Faculty of
Associate Professor, Epidemiology       Medicine, University of Sydney;
Unit, Faculty of Medicine, Prince       Director, Smoking Cessation
of Songkla University, Songkhla,        Unit, and Smokers Clinics, Brain
Thailand                                and Mind Research Institute,
Chapter 4: The scope of intervention;   Camperdown, NSW, Australia
Chapter 24: Special populations         Chapter 8: Tobacco
Associate Professor Tatiana             Associate Professor
Balachova                               Yvonne Bonomo
Associate Professor of Pediatrics,      Associate Professor and Consultant
University of Oklahoma Health           Physician in Addiction Medicine,
Sciences Center, Department             St Vincent’s Hospital Melbourne,
of Pediatrics and the Center            and Departments of Medicine
on Child Abuse and Neglect,             and Paediatrics, University of
University of Oklahoma,                 Melbourne, VC, Australia
Oklahoma City, USA                      Chapter 24: Special populations
Chapter 24: Special populations
                                        Dr Henrietta Bowden-Jones
Professor Robert Batey                  Consultant Psychiatrist, Director
Professor in Hepatology and             and Lead Clinician, National
Addiction Medicine, University          Problem Gambling Clinic and
of Sydney and Flinders University       Honorary Senior Lecturer, Division
South Australia; Consultant             of Brain Science, Imperial College,
Physician, Department of                London, UK
Medicine, Alice Springs Hospital,       Chapter 19: Gambling
Australia
Chapter 9: Alcohol;                     Dr Jonathan Brett
Chapter 11: Opioids;                    Consultant in Clinical
Chapter 18: Injecting drug use          Pharmacology, Toxicology and
                                        Addiction Medicine, Royal Prince
Dr Jenny Bearn                          Alfred Hospital and Clinical
Consultant in Addiction Psychiatry,     Lecturer, University of Sydney;
Maudsley Hospital, South London         Sydney, NSW, Australia
and Maudsley NHS Foundation             Chapter 16: Other drugs;
Trust, UK                               Chapter 25: Substance use and spe-
Chapter 16: Other drugs                 cific healthcare settings
xvi CONTRIBUTORS
  Dr Adam Brodie                       Professor H. Valerie Curran
  Consultant Addiction Psychiatrist,   Professor of Psychopharmacology,
  Clinical Director Addictions (NHS    Clinical Psychopharmacology Unit,
  Lanarkshire), Coathill House,        Brain Sciences, University College
  Coatbridge, UK                       London, UK
  Chapter 16: Other drugs              Chapter 10: Cannabis
  Professor Katherine                  Professor Louisa
  M. Conigrave                         Degenhardt
  Professor in Addiction Medicine      NHMRC Principal Research Fellow
  and Public Health, Sydney            and Professor, National Drug
  Medical School, University of        and Alcohol Research Centre,
  Sydney, and Addiction Medicine       University of New South Wales,
  Specialist, Royal Prince Alfred      Sydney, NSW, Australia
  Hospital, Sydney, Australia          Chapter 2: Epidemiology and
  Chapter 2: Epidemiology and          prevention
  prevention; Chapter 8: Tobacco;
  Chapter 9: Alcohol;                  Associate Professor
  Chapter 11: Opioids;                 Glenys Dore
  Chapter 16: Other drugs;             Clinical Director and Senior Staff
  Chapter 18: Injecting drug use;      Specialist Psychiatrist, Northern
  Chapter 24: Special populations;     Sydney Drug & Alcohol Service,
  Chapter 26: Legal and ethical        and Clinical Associate Professor,
  issues                               University of Sydney, Sydney
                                       Medical School -Northern; Royal
  Professor Jason P. Connor            North Shore Hospital, Sydney,
  Professor of Clinical Psychology,    NSW, Australia
  Discipline of Psychiatry and         Chapter 5: Establishing the diag-
  Centre for Youth Substance           nosis; Chapter 6: Acute care;
  Abuse Research, The University       Chapter 14: Psychostimulants;
  of Queensland, Royal Brisbane        Chapter 22: Psychiatric co-morbidity;
  and Women’s Hospital, QLD,           Chapter 24: Special populations;
  Australia                            Chapter 26: Legal and ethical issues
  Chapter 17: Polysubstance use
                                       Professor Colin Drummond
  Professor Ilana B. Crome             Professor of Addiction Psychiatry,
  Emeritus Professor of Addiction      Addictions Department, National
  Psychiatry, Keele University,        Addiction Centre, Institute
  UK; Honorary Consultant              of Psychiatry, Psychology and
  Psychiatrist, South Staffordshire    Neuroscience, King's College
  and Shropshire Healthcare NHS        London, South London and
  Foundation Trust, Staffordshire,     Maudsley NHS Foundation
  UK; Honorary Professor,              Trust, UK
  Queen Mary University,               Chapter 9: Alcohol
  London, UK; Senior Research
  Fellow, Imperial College
  London, UK
  Chapter 24: Special populations
                                                        CONTRIBUTORS           xvii
Associate Professor Gerald             Professor Wayne Hall
F. X. Feeney                           Director, University of Queensland
Consultant Physician and               Centre for Youth Substance Abuse
Medical Director, Alcohol and          Research and the University
Drug Assessment Unit, Princess         of Queensland Centre Clinical
Alexandra Hospital and the             Research, The University of
Centre for Youth Substance             Queensland, Brisbane, QLD,
Use Research, The University           Australia; and National Addiction
of Queensland, Brisbane, QLD,          Centre, King’s College London, UK
Australia                              Chapter 2: Epidemiology and
Chapter 17: Polysubstance use          prevention
Dr Emily Finch                         Associate Professor
Clinical Director and Consultant       Takayuki Harada
Addiction Psychiatrist, South          Associate Professor, Department
London and Maudsley NHS                of Psychology, Faculty of Human
Foundation Trust, and Addictions       Sciences, Mejiro University,
Clinical Academic Group,               Tokyo, Japan
London, UK                             Chapter 21: Other addictive
Chapter 26: Legal and ethical issues   Disorders
Mr Bradley Freeburn                    Professor Susumu Higuchi
Drug and Alcohol and Mental            Director, National Hospital
Health Unit, Aboriginal Medical        Organization Kurihama Medical
Service, Redfern, NSW, Australia       and Addiction Center and Director
Chapter 24: Special populations        of the World Health Organization
                                       (WHO) Collaborating Centre on
Dr Sanju George                        Research and Training of Alcohol-
Consultant in Addiction Psychiatry,    Related Problems, Kanagawa, Japan
Birmingham and Solihull Mental         Chapter 19: Gambling
Health NHS Foundation Trust,           Chapter 20: Gaming
Birmingham, UK; and now Senior         Chapter 21: Other addictive disorders
Consultant in Psychiatry, Rajagiri
Hospital, Aluva, Kerala, India         Dr Ralph Hingson
Chapter 19: Gambling                   Director, Division of Epidemiology
                                       and Prevention Research, National
Professor Paul Haber                   Institute on Alcohol Abuse and
Clinical Director, Drug Health         Alcoholism, National Institutes of
Services, Sydney Local Health          Health, Bethesda, MD, USA
District; Professor and Head,          Chapter 26: Legal and ethical issues
Discipline of Addiction Medicine,
Sydney Medical School, University      Professor Kazutaka Ikeda
of Sydney, Camperdown, NSW,            Professor, Addictive Substance
Australia                              Project, Tokyo Metropolitan
Chapter 18: Injecting drug use         Institute of Medical Science,
                                       Tokyo, Japan
                                       Chapter 3: Pharmacology and
                                       pathophysiology
xviii CONTRIBUTORS
   Dr Marianne Jauncey                  Professor Michael Levy
   Medical Director, Sydney Medically   Professor, Medical School,
   Supervised Injecting Centre, NSW,    College of Medicine, Biology and
   Australia                            Environment, Australian National
   Chapter 24: Special populations      University, Acton, ACT, Australia
                                        Chapter 24: Special populations
   Associate Professor
   Stephen Jurd                         Ms Corinne Lim
   Consultant Psychiatrist and          Editorial Officer, ‘Addiction
   Associate Professor, Discipline of   Medicine’; formerly The Australian
   Psychological Medicine, Sydney       Financial Review, Fairfax Media
   Medical School, University of        Limited, Australia
   Sydney, and Director of Training     Chapter 24: Special populations
   in Psychiatry, Macquarie Hospital,
   North Ryde, NSW, Australia           Professor Walter Ling
   Chapter 7: Ongoing management of     Integrated Substance Abuse
   substance use disorders              Program (ISAP), School of
                                        Medicine, University of California
   Ms Shivani R. Khan                   at Los Angeles (UCLA), and
   Pre-doctoral Fellow, Department     formerly Commissioner for
   of Epidemiology, College of Public   Narcotics and Dangerous Drugs
   Health and Health Professions &      Commission, Los Angeles,
   College of Medicine, University of   CA, USA
   Florida, Gainesville, FL, USA        Chapter 14: Psychostimulants
   Chapter 16: Other drugs
                                        Professor Anne
   Dr Yasunobu Komoto                   Lingford-Hughes
   Chief of Psychiatry, National        Professor of Addiction Biology,
   Hospital Organization, Kurihama      Centre for Neuropsycho
   Medical and Addiction Center,        pharmacology, Division of Brain
   Yokosuka City, Japan                 Sciences, Department of Medicine,
   Chapter 19: Gambling                 Imperial College London, UK
                                        Chapter 22: Psychiatric co-morbidity
   Dr Noeline C. Latt
   Addiction Medicine Specialist,       Dr E. Jane Marshall
   Royal North Shore Hospital and       Consultant Psychiatrist, Alcohol
   Sydney Medical School, University    Studies Services, South London
   of Sydney, NSW, Australia            and Maudsley National Health
   Chapter 5: Establishing the          Service Trust and the National
   diagnosis; Chapter 6: Acute          Addiction Centre, Institute
   care; Chapter 9: Alcohol;            of Psychiatry, King’s College
   Chapter 11 Opioids;                  London, UK
   Chapter 13: Benzodiazepines          Chapter 6: Acute care;
   and the other sedative-hypnotics;   Chapter 9: Alcohol
   Chapter 23: Specific clinical
   situations; Chapter 26: Legal and
   ethical issues
                                                        CONTRIBUTORS          xix
Professor Ross McCormick               Professor David J. Nutt
Consultant in Addiction Medicine,      Professor of Psychopharmacology,
and Associate Dean (Postgraduate       Division of Brain Science,
Studies), Faculty of Medical and       Department of Medicine,
Health Sciences, University of         Hammersmith Hospital, Imperial
Auckland, New Zealand                  College London, UK, and Founding
Chapter 24: Special populations        Chair of DrugScience (formerly
                                       the Independent Scientific
Ms Satoko Mihara                       Committee on Drugs), UK
Chief, Department of Clinical          Chapter 3: Pharmacology and
Psychology, National Hospital          pathophysiology; Chapter 9: Alcohol;
Organization Kurihama                  Chapter 10: Cannabis;
Medical and Addiction Center,          Chapter 11: Opioids;
Kanagawa, Japan                        Chapter 13: Benzodiazepines
Chapter 21: Other addictive            and the other sedative-hypnotics;
disorders                              Chapter 14: Psychostimulants;
                                       Chapter 15: Hallucinogens and disso-
Professor Hisatsugu Miyata
                                       ciative drugs; Chapter 19: Gambling
Professor, Department of
Psychiatry, Jikei University School    Dr Sally Porter
of Medicine, Tokyo, Japan              Regional Clinical Director, Turning
Chapter 8: Tobacco                     Point Substance Misuse Services,
                                       Croydon, UK
Dr Hideki Nakayama
                                       Chapter 26: Legal and ethical issues
Chief of Psychiatry, National
Hospital Organization Kurihama         Professor Richard Saitz
Medical and Addiction Center,          Chair, Professor of Community
Yokosuka, Japan                        Health Sciences and Medicine,
Chapter 20: Gaming                     Department of Community
Dr Tim Neumann                         Health Sciences, Boston University
                                       Schools of Public Health and
Senior Specialist, Department of
                                       Medicine, Boston, MA, USA
Anaesthesiology and Intensive
                                       Chapter 9: Alcohol;
Care Medicine,
                                       Chapter 25: Substance use and spe-
Charité-Universitätsmedizin Berlin,
                                       cific healthcare settings
Germany
Chapter 25: Substance use and          Dr Hiroshi Sakuma
specific healthcare settings           Chief of Psychiatry, National
Dr Daisuke Nishizawa                   Hospital Organization Kurihama
Addictive Substance Project, Tokyo     Medical and Addiction Center,
Metropolitan Institute of Medical      Kanagawa, Japan
Science, Tokyo, Japan                  Chapter 20: Gaming
Chapter 3: Pharmacology and            Dr Taku Sato
pathophysiology                        Psychiatrist, National Hospital
                                       Organization Kurihama Medical
                                       and Addiction Center, Treatment
                                       of Pathological Gambling and
                                       Research Section, Kanagawa, Japan
                                       Chapter 19: Gambling
xx CONTRIBUTORS
  Professor John B. Saunders               Dr Iain Smith
  Professor and Consultant Physician       Consultant in Addiction Psychiatry,
  in Internal Medicine and Addiction       Kershaw Unit, Gartnavel Royal
  Medicine, University of Queensland,      Hospital, Glasgow, UK
  University of Sydney, and St. John of    Chapter 16: Other drugs
  God Health Care, Wesley Health
  Care, and South Pacific Private          Professor Claudia Spies
  Hospital, Sydney, NSW, Australia         Professor, Department of
  Preface; Chapter 1: The nature of        Anaesthesiology and Intensive
  addictive disorders; Chapter 3:          Care Medicine, Charité-
  Pharmacology and pathophysiol-           Universitätsmedizin Berlin, Germany
  ogy; Chapter 4: The scope of             Chapter 25: Substance use and spe-
  intervention; Chapter 5: Establishing    cific healthcare settings
  the diagnosis; Chapter 6: Acute
                                           Professor Tim Stockwell
  care; Chapter 7: Ongoing man-
  agement of substance use                 Director, Centre for Addictions
  disorders; Chapter 9: Alcohol;           Research of BC and Professor,
  Chapter 10: Cannabis;                    Department of Psychology,
  Chapter 11: Opioids;                     University of Victoria, BC, Canada
  Chapter 13: Benzodiazepines              Chapter 2: Epidemiology and prevention
  and the other sedative-hypnotics;       Professor John Strang
  Chapter 21: Other addictive disorders;
                                           Professor of Addiction Psychiatry
  Chapter 22: Psychiatric co-morbidity;
                                           and Head of Department, National
  Chapter 23: Specific clinical situa-
                                           Addiction Centre, Institute
  tions; Chapter 25: Substance use
                                           of Psychiatry, King’s College
  and specific healthcare settings;
                                           London, UK
  Chapter 26: Legal and ethical issues
                                           Chapter 18: Injecting drug use
  Professor Andrew J. Saxon                Dr Pierluigi Struzzo
  Professor, Department of
                                           General Practitioner, Head of
  Psychiatry & Behavioural Sciences;
                                           the Research and Innovation
  Director, Addiction Psychiatry
                                           Area of the Regional Centre for
  Residency Program, University of
                                           the Training in Primary Care,
  Washington; WA, USA; Director,
                                           Department of Life Sciences,
  Center of Excellence in Substance
                                           University of Trieste, Italy
  Abuse Treatment and Education
                                           Chapter 25: Substance use and spe-
  (CESATE), VA Puget Sound Health
                                           cific healthcare settings
  Care System, Seattle, WA, USA
  Chapter 11: Opioids                      Assistant Professor
  Professor Janie Sheridan                 Catherine Woodstock Striley
                                           Assistant Professor, Department
  Professor, School of Pharmacy and
                                           of Epidemiology, College of Public
  Centre for Addiction Research,
                                           Health and Health Professions,
  Faculty of Medical and Health
                                           College of Medicine, University of
  Sciences, The University of
                                           Florida, Gainesville, FL, USA
  Auckland, New Zealand
                                           Chapter 16: Other drugs
  Chapter 16: Other drugs
                                                            CONTRIBUTORS       xxi
Professor David Taylor                     Professor Kim Wolff
Director of Pharmacy and                   Professor in Addiction Science,
Pathology, South London and                King’s College London, Institute
Maudsley NHS Foundation Trust,             of Pharmaceutical Science,
Pharmacy Department, Maudsley              London, UK
Hospital, London, UK                       Chapter 24: Special populations
Chapter 16: Other drugs
                                           Professor George Woody
Associate Professor Peter                  Professor, Department of
Thompson                                   Psychiatry, University of
Senior Staff Specialist, Emergency         Pennsylvania and Treatment
Medicine, and Associate                    Research Institute, Philadelphia,
Professor, Rural Clinical School,          PA, USA
Rockhampton, QLD, Australia                Chapter 11: Opioids
Chapter 6: Acute care
                                           Professor Nicholas Zwar
Dr Sue Wilson                              Professor of General Practice,
Senior Research Fellow, Centre             School of Public Health and
for Neuropsychopharmacology,               Community Medicine, University
Division of Brain Sciences, Imperial       of New South Wales, Sydney,
College London, UK                         NSW, Australia
Chapter 23: Specific clinical situations   Chapter 8: Tobacco
Dr Adam R. Winstock
Consultant Psychiatrist and
Addiction Medicine Specialist,
South London and Maudsley NHS
Trust; Senior Lecturer, King’s
College London, UK
Chapter 15: Hallucinogens
and dissociative drugs;
Chapter 16: Other drugs
                                                              xxiii
        Symbols and abbreviations
5HIAA       5-hydroxyindoleacetic acid
5HT         5-hydroxytryptamine (serotonin)
AA          Alcoholics Anonymous
Ab          antibody
ACE         angiotensin-converting enzyme
ADH         antidiuretic hormone
ADHD        attention deficit hyperactivity disorder
ADIS        Alcohol and Drug Information Service, Australia
AFP         alpha-fetoprotein
Ag          antigen
AIDS        acquired immune deficiency syndrome
ALP         alkaline phosphatase
ALT         alanine aminotransferase
Anti-HBc   anti-hepatitis B core antibody
Anti-HBe   anti-hepatitis B e antibody
Anti-HBs   anti-hepatitis B surface antibody
Anti-HCV   hepatitis C antibody
APTT        activated partial thromboplastin time
ARND        alcohol-related neurodevelopment disorder
ASI         Addiction Severity Index
ASPD        antisocial personality disorder
ASSIST      Alcohol, Smoking and Substance Involvement
            Screening Test
AST         aspartate aminotransferase
ATS         amphetamine-type stimulants
AUD         alcohol use disorder
AUDIT       Alcohol Use Disorders Identification Test
AWS         Alcohol Withdrawal Scale
BAC         blood alcohol concentration
BAP         British Association of Psychopharmacology
BBV         blood-borne virus
BP          blood pressure
xxiv SYMBOLS AND ABBREVIATIONS
   BWS           Benzodiazepine Withdrawal Scale
   CAGE          acronym for four alcoholism screening questions
   CAL           chronic airways limitation (also known as COPD)
   CB1           cannabinoid receptor type 1
   CB2           cannabinoid receptor type 2
   CBD           cannabidiol
   CBT           cognitive behavioural therapy
   CCF           congestive cardiac failure
   CDT           carbohydrate deficient transferrin
   CIDI          Composite International Diagnostic Interview
   CIWA-Ar      Clinical Institute Withdrawal Assessment for
                 Alcohol-revised
   CIWA-B       Clinical Institute Withdrawal Assessment for
                 Benzodiazepines
   CK-MB        creatine kinase isoenzyme
   C-L          consultation-liaison
   CNS           central nervous system
   CO            carbon monoxide
   COMT          catechol-O-methyltransferase
   COPD          chronic obstructive pulmonary disease
   CPK           creatine phosphokinase
   CRP           C-reactive protein
   CT            computed tomography
   CVS           cardiovascular system
   CXR           chest X-ray
   DA            dopamine
   DALY          disability-adjusted life year
   DD            differential diagnosis
   DDS           Delirium Detection Scale
   DIS           Diagnostic Interview Schedule
   DNA           deoxyribonucleic acid
   DSM-IV       Diagnostic and Statistical Manual, 4th edition
   DSM-5        Diagnostic and Statistical Manual, 5th edition
   DTs           delirium tremens
   DVLA          Driver and Vehicle Licensing Agency (UK)
   ECG           electrocardiogram
                           SYMBOLS AND ABBREVIATIONS           xxv
ECHO    echocardiogram
ED      emergency department
EDOU    emergency department observation unit
EEG     electroencephalogram
EMR     Eastern Mediterranean region
ERCP    endoscopic retrograde cholangiopancreatography
ESR     erythrocyte sedimentation rate
EU      European Union
EUC     electrolytes, urea, and creatinine
FAE     fetal alcohol effects
FAS     fetal alcohol syndrome
FASD    fetal alcohol spectrum disorder
FBC     full blood count
FCTC    World Health Organization Framework Convention
        on Tobacco Control
FLAGS   Feedback, Listen, Advice, Goals, Strategies (acronym
        for core elements of brief intervention)
fMRI    functional magnetic resonance imaging
FTQ     Fagerström tolerance questionnaire
GABA    gamma aminobutyric acid
GAD     generalized anxiety disorder
GCS     Glasgow coma scale
GDP     gross domestic product
GGT     gamma-glutamyl transferase
GHB     gamma hydroxybutyrate
GI      gastrointestinal
GIT     gastrointestinal tract
GP      general practitioner
HADS    Hospital Anxiety and Depression Scale
Hb      haemoglobin
HBcAb   hepatitis B core antibody
HBeAg   hepatitis B e antigen
HBsAg   hepatitis B surface antigen
HBV     hepatitis B virus
Hct     haematocrit
HCV     hepatitis C virus
xxvi SYMBOLS AND ABBREVIATIONS
   HCV Ab         anti-hepatitis C antibody
   HDL            high-density lipoprotein
   HDV            hepatitis D virus
   HIV            human immunodeficiency virus
   HoNOS          Health of the Nation Outcome Scales
   h              hour(s)
   ICD 10        International Classification of Diseases, 10th
                  revision
   IDU            injecting drug user
   IgG            immunoglobulin G
   IgM            immunoglobulin M
   IM             intramuscular
   INR            international normalized ratio
   IV             intravenous
   IU             international units
   IUGR           intra-uterine growth retardation
   K, Special K   ketamine
   kg             kilogram(s)
   L              litre(s)
   LDL            low-density lipoprotein
   LFT            liver function test
   LSD            lysergic acid
   MAOI           monoamine oxidase inhibitor
   mcg            microgram(s)
   MCV            mean corpuscular volume
   MDMA           methylenedioxymethamphetamine
   MEOS           microsomal ethanol oxidizing system
   min            minute(s)
   mL             millilitre(s)
   mmHg           millimetres of mercury
   MRI            magnetic resonance imaging
   MRSA           meticillin-resistant Staphylococcus aureus
   MSE            Mental State Examination
   NA             Narcotics Anonymous
   NAD            nicotinamide adenine dinucleotide (oxidized form)
                           SYMBOLS AND ABBREVIATIONS       xxvii
NADH    nicotinamide adenine dinucleotide (reduced form)
NARS    Nicotine Assisted Reduction to Stop
NaSSA   noradrenaline and specific serotonergic agent
ng      nanograms(s)
NMDA    N-methyl-D-aspartate
NMS     neuroleptic malignant syndrome
nocte   at night
NRT     nicotine replacement therapy
NSAID   non-steroidal anti-inflammatory drug
OCD     obsessive–compulsive disorder
OST     opioid substitution treatment
OTC     over-the-counter
PAT     Paddington alcohol test
PAE     prenatal alcohol exposure
PCP     phencyclidine
PCR     polymerase chain reaction
PET     positron emission tomography
PFC     prefrontal cortex
PMA     para-methoxyamphetamine
PO      per oral (orally)
PPP     purchasing power parity
PRN     pro re nata (as required)
PTSD    post-traumatic stress disorder
RASS    Richmond Agitation-Sedation Scale
RIMA    reversible inhibitor of monoamine oxidase A
RNA     ribonucleic acid
RTA     road traffic accidents
SAD     social anxiety disorder
SADQ    Severity of Alcohol Dependence Questionnaire
SAM     substance abuse module
SC      subcutaneous
SCAN    Schedules for Clinical Assessment in
        Neuropsychiatry
SDS     Severity of Dependence Scale
sec     second(s)
xxviii SYMBOLS AND ABBREVIATIONS
    SF14, SF36, SF96   quality of life questionnaires
    SIDS               sudden infant death syndrome
    SE                 side effects
    SL                 sublingual
    SNRI               serotonin and noradrenaline reuptake inhibitor
    SNS                social networking service
    SODQ               Severity of Opiate Dependence Questionnaire
    SSRI               selective serotonin reuptake inhibitor
    STI                sexually transmitted infection
    t½                 half-life
    TB                 tuberculosis
    TCA                tricyclic antidepressant
    TFT                thyroid function test
    THC                tetrahydrocannabinol
    TIA                transient ischaemic attacks
    TSH                thyroid-stimulating hormone
    TTFC               time to first cigarette
    TWEAK              Tolerance, Worried, Eye-opener, Amnesia, K/
                       Cut-down
    UN                 United Nations
    UNODC              United Nations Office on Drugs and Crime
    VDRL               venereal diseases research laboratory test for
                       syphilis
    VSM                volatile solvent misuse
    VTA                ventral tegmental area
    WBC                white blood cell count
    WE                 Wernicke’s encephalopathy
    WHO                World Health Organization
    WPR                Western Pacific Region
Exploring the Variety of Random
Documents with Different Content
                 APRIL 15. (Wednesday.)
   About noon to-day a well-disposed healthy lad of seventeen years
of age was employed in unhaltering the first pair of oxen of one of
the waggons, in doing which he entangled his right leg in the rope.
At that moment the oxen set off full gallop, and dragged the boy
along with them round the whole inclosure, before the other negroes
could succeed in stopping them. However, when the prisoner was
extricated, although his flesh appeared to have been terribly
lacerated, no bones were broken, and he was even able to walk to
the hospital without support. He was blooded instantly, and two
physicians were sent for by express. At two o’clock he was still in
perfect possession of his senses, and only complained of the
soreness of his wounds: but in half an hour after he became
apoplectic; sank into a state of utter insensibility, during which a
dreadful rattling in his throat was the only sign of still existing life,
and before six in the evening all was over with him!
                            APRIL 17.
   Pickle had accused his brother-in-law, Edward the Eboe, of having
given him a pleurisy by the practice of Obeah. During my last visit I
had convinced him that the charge was unjust (or at least he had
declared himself to be convinced), and about six weeks ago they
came together to assure me, that ever since they had lived upon the
best terms possible. Unluckily, Pickle’s wife miscarried lately, and for
the third time; previously to which Edward had said, that his wife
would remain sole heiress of the father’s property. This was enough
to set the suspicious brains of these foolish people at work; and to-
day Pickle and his father-in-law, old Damon, came to assure me, that
in order to prevent a child coming to claim its share of the
grandfather’s property, Edward had practised Obeah to make his
sister-in-law miscarry; the only proof of which adduced was the
above expression, and the woman’s having miscarried “just
according to Edward’s very words!” To reason with such very absurd
persons was out of the case. I found too, that the two sisters were
quarrelling perpetually, and always on the point of tearing each
other’s eyes out. Therefore, as domestic peace “in a house so
disunited” was out of the question, I ordered the two families to
separate instantly, and to live at the two extremities of the negro
village; at the same time forbidding all intercourse between them
whatsoever: a plan, which was received with approbation by all
parties; and Edward moved his property out of the old man’s house
into another without loss of time. Among other charges of Obeah,
Pickle declared, that his house having been robbed, Edward had told
him that Nato was the offender; and in order to prove it beyond the
power of doubt, he had made him look at something round, “just
like massa’s watch,” out of which he had taken a sentee (a
something) which looked like an egg; this he gave to Pickle, at the
same time instructing him to throw it at night against the door of
Nato’s house; which he had no sooner done and broken the egg,
than the very next day Nato’s wife Philippa “began to bawl, and
halloo, and went mad.” Now that Philippa had bawled and hallooed
enough was certainly true; but it was also true that she had
confessed her madness to have been a trick for the purpose of
exciting my compassion, and inducing me to feed her from my own
table. Yet was this simple fellow persuaded that he had made her go
mad by the help of his broken egg, and his old fool of a father-in-law
was goose enough to encourage him in the persuasion.
                   APRIL 19. (Sunday.)
   “And massa,” said Bridget, the doctoress, this morning, “my old
mother a lilly so-so to-day; and him tank massa much for the good
supper massa send last night; and him like it so well.—Laud! massa,
the old lady was just thinking what him could yam (eat) and him no
fancy nothing; and him could no yam salt, and him just wishing for
something fresh, when at that very moment Cu-bina come to him
from massa with a stewed pig’s head so fresh: it seemed just as if
massa had got it from the Almighty’s hands himself.”
                           APRIL 22.
   Naturalists and physicians, philosophers and philanthropists, may
argue and decide as they please; but certainly, as far as mere
observation admits of my judging, there does seem to be a very
great difference between the brain of a black person and a white
one. I should think that Voltaire would call a negro’s reason “une
raison très particulière.” Somehow or other, they never can manage
to do anything quite as it should be done. If they correct themselves
in one respect to-day they are sure of making a blunder in some
other manner to-morrow. Cubina is now twenty-five, and has all his
life been employed about the stable; he goes out with my carriage
twice every day; yet he has never yet been able to succeed in
putting on the harness properly. Before we get to one of the
plantation gates we are certain of being obliged to stop, and put
something or other to rights: and I once remember having laboured
for more than half an hour to make him understand that the
Christmas holidays came at Christmas; when asked the question, he
always hesitated, and answered, at hap-hazard, “July” or “October.”
Yet, Cubina is far superior in intellect to most of the negroes who
have fallen under my observation. The girl too, whose business it is
to open the house each morning, has in vain been desired to unclose
all the jalousies: she never fails to leave three or four closed, and
when she is scolded for doing so, she takes care to open those three
the next morning, and leaves three shut on the opposite side.
Indeed, the attempt to make them correct a fault is quite fruitless:
they never can do the same thing a second time in the same
manner; and if the cook having succeeded in dressing a dish well is
desired to dress just such another, she is certain of doing something
which makes it quite different. One day I desired, that there might
be always a piece of salt meat at dinner, in order that I might be
certain of always having enough to send to the sick in the hospital.
In consequence, there was nothing at dinner but salt meat. I
complained that there was not a single fresh dish, and the next day,
there was nothing but fresh. Sometimes there is scarcely anything
served up, and the cook seems to have forgotten the dinner
altogether: she is told of it; and the next day she slaughters without
mercy pigs, sheep, fowls, ducks, turkeys, and everything that she
can lay her murderous hands upon, till the table absolutely groans
under the load of her labours. For above a month Cubina and I had
perpetual quarrels about the cats being shut into the gallery at
nights, where they threw down plates, glasses, and crockery of all
kinds, and made such a clatter that to get a wink of sleep was quite
out of the question. Cubina, before he went to rest, hunted under all
the beds and sofas, and laid about him with a long whip for half an
hour together; but in half an hour after his departure the cats were
at work again. He was then told, that although he had turned them
out, he must certainly have left some window open: he promised to
pay particular attention to this point, but that night the uproar was
worse than ever; yet he protested that he had carefully turned out
all the cats, locked all the doors, and shut all the windows. He was
told, that if he had really turned out all the cats, the cats must have
got in again, and therefore that he must have left some one window
open at least. “No,” he said, “he had not left one; but a pane in one
of the windows had been broken two months before, and it was
there that the cats got in whenever they pleased.” Yet he had
continued to turn the cats out of the door with the greatest care,
although he was perfectly conscious that they could always walk in
again at the window in five minutes after. But the most curious of
Cubina’s modes of proceeding is, when it is necessary for him to
attack the pigeon-house. He steals up the ladder as slily and as
softly as foot can fall; he opens the door, and steals in his head with
the utmost caution; on which, to his never-failing surprise and
disappointment, all the pigeons make their escape through the open
holes; he has now no resource but entering the dove-cot, and
remaining there with unwearied patience for the accidental return of
the birds, which nine times out of ten does not take place till too late
for dinner, and Cubina returns empty-handed. Having observed this
proceeding constantly repeated during a fortnight, I took pity upon
his embarrassment, and ordered two wooden sliders to be fitted to
the holes. Cubina was delighted with this exquisite invention, and
failed not the next morning to close all the holes on the right with
one of the sliders; he then stepped boldly into the dove-cot, when to
his utter confusion the pigeons flew away through the holes on the
left. Here then he discovered where the fault lay, so he lost no time
in closing the remaining aperture with the second slider, and the
pigeons were thus prevented from returning at all. Cubina waited
long with exemplary patience, but without success, so he abandoned
the new invention in despair, made no farther use of the sliders, and
continues to steal up the ladder as he did before. A few days ago,
Nicholas, a mulatto carpenter, was ordered to make a box for the
conveyance of four jars of sweetmeats, of which he took previous
measure; yet first he made a box so small that it would scarcely hold
a single jar, and then another so large that it would have held
twenty; and when at length he produced one of a proper size, he
brought it nailed up for travelling (although it was completely
empty), and nailed up so effectually too, that on being directed to
open it that the jars might be packed, he split the cover to pieces in
the attempt to take it off. Yet, among all my negroes, Nicholas and
Cubina are not equalled for adroitness and intelligence by more than
twenty. Judge then what must be the remaining three hundred!
                           APRIL 23.
   In my medical capacity, like a true quack I sometimes perform
cures so unexpected, that I stand like Katterfelto, “with my hair
standing on end at my own wonders.” Last night, Alexander, the
second governor, who has been seriously ill for some days, sent me
word, that he was suffering cruelly from a pain in his head, and
could get no sleep. I knew not how to relieve him; but having
frequently observed a violent passion for perfumes in the house
negroes, for want of something else I gave the doctoress some oil of
lavender, and told her to rub two or three drops upon his nostrils.
This morning, he told me that “to be sure what I had sent him was a
grand medicine indeed,” for it had no sooner touched his nose than
he felt some-thing cold run up to his forehead, over his head, and all
the way down his neck to the back-bone; instantly, the headach left
him, he fell fast asleep, nor had the pain returned in the morning.
But I am afraid, that even this wonderful oil would fail of curing a
complaint which was made to me a few days ago. A poor old
creature, named Quasheba, made her appearance at my breakfast
table, and told me, “that she was almost eighty, had been rather
weakly for some time past, and somehow she did not feel as she
was by any means right.”
  “Had she seen the doctor? Did she want physic?”
  “No, she had taken too much physic already, and the doctor would
do her no good; she did not want to see the doctor.”
  “But what then was her complaint?”
  “Oh! she had no particular complaint; only she was old and
weakly, and did not find herself by any means so well as she used to
be, and so she came just to tell massa, and see what he could do to
make her quite right again, that was all.” In short, she only wanted
me to make her young again!
                          APRIL 24.
   Mr. Forbes is dead. When I was last in Jamaica, he had just been
poisoned with corrosive sublimate by a female slave, who was
executed in consequence. He never was well afterwards; but as he
lived intemperately, the whole blame of his death must not be laid
upon the poison.
                          APRIL 30.
  A free mulatto of the name of Rolph had frequently been
mentioned to me by different magistrates, as remarkable for the
numerous complaints brought against him for cruel treatment of his
negroes. He was described to me as the son of a white ploughman,
who at his death left his son six or seven slaves, with whom he
resides in the heart of the mountains, where the remoteness of the
situation secures him from observation or control. His slaves, indeed,
every now and then contrive to escape, and come down to
Savannah la Mar to lodge their complaints; but the magistrates,
hitherto, had never been able to get a legal hold upon him. However,
a few days ago, he entered the house of a Mrs. Edgins, when she
was from home, and behaving in an outrageous manner to her
slaves, he was desired by the head-man to go away. Highly
incensed, he answered, “that if the fellow dared to speak another
word, it should be the last that he should ever utter.” The negro
dared to make a rejoinder; upon which Rolph aimed a blow at him
with a stick, which missed his intended victim, but struck another
slave who was interposing to prevent a scuffle, and killed him upon
the spot. The murder was committed in the presence of several
negroes; but negroes are not allowed to give evidence, and as no
free person was present, there are not only doubts whether the
murderer will be punished, but whether he can even be put upon his
trial.
                       MAY 1. (Friday.)
   This morning I signed the manumission of Nicholas Cameron, the
best of my mulatto carpenters. He had been so often on the very
point of getting his liberty, and still the cup was dashed from his lips,
that I had promised to set him free, whenever he could procure an
able negro as his substitute; although being a good workman, a
single negro was by no means an adequate price in exchange. On
my arrival this year I found that he had agreed to pay £150 for a
female negro, and the woman was approved of by my trustee. But
on enquiry it appeared that she had a child, from which she was
unwilling to separate, and that her owner refused to sell the child,
except at a most unreasonable price. Here then was an
insurmountable objection to my accepting her, and Nicholas was told
to his great mortification, that he must look out for another
substitute. The woman, on her part, was determined to belong to
Cornwall estate and no other: so she told her owner, that if he
attempted to sell her elsewhere she would make away with herself,
and on his ordering her to prepare for a removal to a neighbouring
proprietor’s, she disappeared, and concealed herself so well, that for
some time she was believed to have put her threats of suicide into
execution. The idea of losing his £150 frightened her master so
completely, that he declared himself ready to let me have the child
at a fair price, as well as the mother, if she ever should be found;
and her friends having conveyed this assurance to her, she thought
proper to emerge from her hiding-place, and the bargain was
arranged finally. The titles, however, were not yet made out, and as
the time of my departure for Hordley was arrived, these were
ordered to be got ready against my return, when the negroes were
to be delivered over to me, and Nicholas was to be set free. In the
meanwhile, the child was sent by her mistress (a free mulatto) to
hide some stolen ducks upon a distant property, and on her return
blabbed out the errand: in consequence the mistress was committed
to prison for theft; and no sooner was she released, than she
revenged herself upon the poor girl by giving her thirty lashes with
the cattle-whip, inflicted with all the severity of vindictive malice.
This treatment of a child of such tender years reduced her to such a
state, as made the magistrates think it right to send her for
protection to the workhouse, until the conduct of the mistress should
have been enquired into. In the meanwhile, as the result of the
enquiry might be the setting the girl at liberty, the joint title for her
and her mother could not be made out, and thus poor Nicholas’s
manumission was at a stand-still again. The magistrates at length
decided, that although the chastisement had been severe, yet
(according to the medical report) it was not such as to authorise the
sending the mistress to be tried at the assizes. She was accordingly
dismissed from farther investigation, and the girl was once more
considered as belonging to me, as soon as the title could be made
out. But the fatality which had so often prevented Nicholas from
obtaining his freedom, was not weary yet. On the very morning,
when he was to sign the title, a person whose signature was
indispensable, was thrown out of his chaise, the wheel of which
passed over his head, and he was rendered incapable of transacting
business for several weeks. Yesterday, the titles were at length
brought to me complete, and this morning put Nicholas in
possession of the object, in the pursuit of which he has experienced
such repeated disappointments. The conduct of the poor child’s
mulatto mistress in this case was most unpardonable, and is only
one of numerous instances of a similar description, which have been
mentioned to me. Indeed, I have every reason to believe, that
nothing can be uniformly more wretched, than the life of the slaves
of free people of colour in Jamaica; nor would any thing contribute
more to the relief of the black population, than the prohibiting by
law any mulatto to become the owner of a slave for the future. Why
should not rich people of colour be served by poor people of colour,
hiring them as domestics? It seldom happens that mulattoes are in
possession of plantations; but when a white man dies, who happens
to possess twenty negroes, he will divide them among his brown
family, leaving (we may say) five to each of his four children. These
are too few to be employed in plantation work; they are, therefore,
ordered to maintain their owner by some means or other, and which
means are frequently not the most honest, the most frequent being
the travelling about as higglers, and exchanging the trumpery
contents of their packs and boxes with plantation negroes for stolen
rum and sugar. I confess I cannot see why, on such bequest being
made, the law should not order the negroes to be sold, and the
produce of the sale paid to the mulatto heirs, but absolutely
prohibiting the mulattoes from becoming proprietors of the negroes
themselves. Every man of humanity must wish that slavery, even in
its best and most mitigated form, had never found a legal sanction,
and must regret that its system is now so incorporated with the
welfare of Great Britain as well as of Jamaica, as to make its
extirpation an absolute impossibility, without the certainty of
producing worse mischiefs than the one which we annihilate. But
certainly there can be no sort of occasion for continuing in the
colonies the existence of do-mestic slavery, which neither
contributes to the security of the colonies themselves, nor to the
opulence of the mother-country, the revenue of which derived from
colonial duties would suffer no defalcation whatever, even if neither
whites nor blacks in the West Indies were suffered to employ slaves,
except in plantation labour.
                              MAY 2.
   I gave my negroes a farewell holiday, on which occasion each
grown person received a present of half-a-dollar, and every child a
maccaroni. In return, they endeavoured to express their sorrow for
my departure, by eating and drinking, dancing and singing, with
more vehemence and perseverance than on any former occasion. As
in all probability many years will elapse without my making them
another visit, if indeed I should ever return at all, I have at least
exerted myself while here to do everything which appeared likely to
contribute to their welfare and security during my absence. In
particular, my attorney has made out a list of all such offences as are
most usually committed on plantations, to which proportionate
punishments have been affixed by myself. From this code of internal
regulations the overseer is not to be allowed to deviate, and the
attorney has pledged himself in the most solemn manner to adhere
strictly to the system laid down for him. By this scheme, the negroes
will no longer be punished according to the momentary caprice of
their superintendent, but by known and fixed laws, the one no more
than the other, and without respect to partiality or prejudice.
Hitherto, in everything which had not been previously deter mined
by the public law, with a penalty attached to the breach of it, the
negro has been left entirely at the mercy of the overseer, who if he
was a humane man punished him slightly, and if a tyrant, heavily;
nay, very often the quantity of punishment depended upon the time
of day when the offence was made known. If accused in the
morning, when the overseer was in cold blood and in good humour,
a night’s confinement in the stocks might be deemed sufficient;
whereas if the charge was brought when the superior had taken his
full proportion of grog or sangaree, the very same offence would be
visited with thirty-nine lashes. I have, moreover, taken care to settle
all disputes respecting property, having caused all negroes having
claims upon others to bring them before my tribunal previous to my
departure, and determined that from that time forth no such claims
should be enquired into, but considered as definitively settled by my
authority. It would have done the Lord Chancellor’s heart good to
see how many suits I determined in the course of a week, and with
what expedition I made a clear court of chancery. But perhaps the
most astonishing part of the whole business was, that after
judgment was pronounced, the losers as well as the gainers declared
themselves perfectly satisfied with the justice of the sentence. I
must acknowledge, however, that the negro principle that “massa
can do no wrong,” was of some little assistance to me on this
occasion. “Oh! quite just, me good, massa! what massa say, quite
just! me no say nothing more; me good, massa!” Then they thanked
me “for massa’s goodness in giving them so long talk!” and went
away to tell all the others “how just massa had been in taking away
what they wanted to keep, or not giving them what they asked for.”
It must be owned that this is not the usual mode of proceeding after
the loss of a chancery suit in England. But to do the negroes mere
justice, I must say, that I could not have wished to find a more
tractable set of people on almost every occasion. Some lazy and
obstinate persons, of course, there must inevitably be in so great a
number; but in general I found them excellently disposed, and being
once thoroughly convinced of my real good-will towards them, they
were willing to take it for granted, that my regulations must be right
and beneficial, even in cases where they were in opposition to
individual interests and popular prejudices. My attorney had
mentioned to me several points, which he thought it advisable to
have altered, but which he had vainly endeavoured to accomplish.
Thus the negroes were in the practice of bequeathing their houses
and grounds, by which means some of them were become owners
of several houses and numerous gardens in the village, while others
with large families were either inadequately provided for, or not
provided for at all. I made it public, that from henceforth no negro
should possess more than one house, with a sufficient portion of
ground for his family, and on the following Sunday the overseer by
my order looked over the village, took from those who had too much
to give to those who had too little, and made an entire new
distribution according to the most strict Agrarian law. Those who lost
by this measure, came the next day to complain to me; when I
avowed its having been done by my order, and explained the
propriety of the proceeding; after which they declared themselves
contented, and I never heard another murmur on the subject. Again,
mothers being allowed certain indulgences while suckling, persist in
it for two years and upwards, to the great detriment both of
themselves and their children: complaint of this being made to me, I
sent for the mothers, and told them that every child must be sent to
the weaning-house on the first day of the fifteenth month, but that
their indulgences should be continued to the mothers for two
months longer, although the children would be no longer with them.
All who had children of that age immediately gave them up; the rest
promised to do so, when they should be old enough $ and they all
thanked me for the continuance of their indulgences, which they
considered as a boon newly granted them. On my return from
Hordley, I was told that the negroes suffered their pigs to infest the
works and grounds in the immediate vicinity of the house in such
numbers, that they were become a perfect nuisance; nor could any
remonstrance prevail on them to confine the animals within the
village. An order was in consequence issued on a Saturday, that the
first four pigs found rambling at large after two days should be put
to death without mercy; and accordingly on Monday morning, at the
negro breakfast hour, the head governor made his appearance
before the house, armed cap-a-pee, with a lance in his hand, and an
enormous cutlass by his side. The news of this tremendous
apparition spread through the estate like wildfire. Instantly all was in
an uproar; the negroes came pouring down from all quarters; in an
instant the whole air was rent with noises of all kinds and creatures;
men, women, and children shouting and bellowing, geese cackling,
dogs barking, turkeys gobbling; and, look where you would, there
was a negro running along as fast as he could, and dragging a pig
along with him by one of the hind legs, while the pigs were all
astonishment at this sudden attack, and called upon heaven and
earth for commiseration and protection,—
            “With many a doleful grunt and piteous squeak,
            Poor pigs! as if their pretty hearts would break!”
   From thenceforth not a pig except my own was to be seen about
the place; yet instead of complaining of this restraint, several of the
negroes came to assure me, that I might depend on the animals not
being suffered to stray beyond the village for the future, and to
thank me for having given them the warning two days before. What
other negroes may be, I will not pretend to guess; but I am certain
that there cannot be more tractable or better disposed persons (take
them for all in all) than my negroes of Cornwall. I only wish, that in
my future dealings with white persons, whether in Jamaica or out of
it, I could but meet with half so much gratitude, affection, and good-
will.
                            THE END.
  *** END OF THE PROJECT GUTENBERG EBOOK JOURNAL OF A
               WEST INDIA PROPRIETOR ***
Updated editions will replace the previous one—the old editions will
be renamed.
Creating the works from print editions not protected by U.S.
copyright law means that no one owns a United States copyright in
these works, so the Foundation (and you!) can copy and distribute it
in the United States without permission and without paying
copyright royalties. Special rules, set forth in the General Terms of
Use part of this license, apply to copying and distributing Project
Gutenberg™ electronic works to protect the PROJECT GUTENBERG™
concept and trademark. Project Gutenberg is a registered trademark,
and may not be used if you charge for an eBook, except by following
the terms of the trademark license, including paying royalties for use
of the Project Gutenberg trademark. If you do not charge anything
for copies of this eBook, complying with the trademark license is
very easy. You may use this eBook for nearly any purpose such as
creation of derivative works, reports, performances and research.
Project Gutenberg eBooks may be modified and printed and given
away—you may do practically ANYTHING in the United States with
eBooks not protected by U.S. copyright law. Redistribution is subject
to the trademark license, especially commercial redistribution.
                       START: FULL LICENSE
THE FULL PROJECT GUTENBERG LICENSE
        PLEASE READ THIS BEFORE YOU DISTRIBUTE OR USE THIS WORK
To protect the Project Gutenberg™ mission of promoting the free
distribution of electronic works, by using or distributing this work (or
any other work associated in any way with the phrase “Project
Gutenberg”), you agree to comply with all the terms of the Full
Project Gutenberg™ License available with this file or online at
www.gutenberg.org/license.
      Section 1. General Terms of Use and
      Redistributing Project Gutenberg™
      electronic works
1.A. By reading or using any part of this Project Gutenberg™
electronic work, you indicate that you have read, understand, agree
to and accept all the terms of this license and intellectual property
(trademark/copyright) agreement. If you do not agree to abide by all
the terms of this agreement, you must cease using and return or
destroy all copies of Project Gutenberg™ electronic works in your
possession. If you paid a fee for obtaining a copy of or access to a
Project Gutenberg™ electronic work and you do not agree to be
bound by the terms of this agreement, you may obtain a refund
from the person or entity to whom you paid the fee as set forth in
paragraph 1.E.8.
1.B. “Project Gutenberg” is a registered trademark. It may only be
used on or associated in any way with an electronic work by people
who agree to be bound by the terms of this agreement. There are a
few things that you can do with most Project Gutenberg™ electronic
works even without complying with the full terms of this agreement.
See paragraph 1.C below. There are a lot of things you can do with
Project Gutenberg™ electronic works if you follow the terms of this
agreement and help preserve free future access to Project
Gutenberg™ electronic works. See paragraph 1.E below.
1.C. The Project Gutenberg Literary Archive Foundation (“the
Foundation” or PGLAF), owns a compilation copyright in the
collection of Project Gutenberg™ electronic works. Nearly all the
individual works in the collection are in the public domain in the
United States. If an individual work is unprotected by copyright law
in the United States and you are located in the United States, we do
not claim a right to prevent you from copying, distributing,
performing, displaying or creating derivative works based on the
work as long as all references to Project Gutenberg are removed. Of
course, we hope that you will support the Project Gutenberg™
mission of promoting free access to electronic works by freely
sharing Project Gutenberg™ works in compliance with the terms of
this agreement for keeping the Project Gutenberg™ name associated
with the work. You can easily comply with the terms of this
agreement by keeping this work in the same format with its attached
full Project Gutenberg™ License when you share it without charge
with others.
1.D. The copyright laws of the place where you are located also
govern what you can do with this work. Copyright laws in most
countries are in a constant state of change. If you are outside the
United States, check the laws of your country in addition to the
terms of this agreement before downloading, copying, displaying,
performing, distributing or creating derivative works based on this
work or any other Project Gutenberg™ work. The Foundation makes
no representations concerning the copyright status of any work in
any country other than the United States.
1.E. Unless you have removed all references to Project Gutenberg:
1.E.1. The following sentence, with active links to, or other
immediate access to, the full Project Gutenberg™ License must
appear prominently whenever any copy of a Project Gutenberg™
work (any work on which the phrase “Project Gutenberg” appears,
or with which the phrase “Project Gutenberg” is associated) is
accessed, displayed, performed, viewed, copied or distributed:
       This eBook is for the use of anyone anywhere in the
       United States and most other parts of the world at no
       cost and with almost no restrictions whatsoever. You
       may copy it, give it away or re-use it under the terms
       of the Project Gutenberg License included with this
       eBook or online at www.gutenberg.org. If you are not
       located in the United States, you will have to check the
       laws of the country where you are located before using
       this eBook.
1.E.2. If an individual Project Gutenberg™ electronic work is derived
from texts not protected by U.S. copyright law (does not contain a
notice indicating that it is posted with permission of the copyright
holder), the work can be copied and distributed to anyone in the
United States without paying any fees or charges. If you are
redistributing or providing access to a work with the phrase “Project
Gutenberg” associated with or appearing on the work, you must
comply either with the requirements of paragraphs 1.E.1 through
1.E.7 or obtain permission for the use of the work and the Project
Gutenberg™ trademark as set forth in paragraphs 1.E.8 or 1.E.9.
1.E.3. If an individual Project Gutenberg™ electronic work is posted
with the permission of the copyright holder, your use and distribution
must comply with both paragraphs 1.E.1 through 1.E.7 and any
additional terms imposed by the copyright holder. Additional terms
will be linked to the Project Gutenberg™ License for all works posted
with the permission of the copyright holder found at the beginning
of this work.
1.E.4. Do not unlink or detach or remove the full Project
Gutenberg™ License terms from this work, or any files containing a
part of this work or any other work associated with Project
Gutenberg™.
1.E.5. Do not copy, display, perform, distribute or redistribute this
electronic work, or any part of this electronic work, without
prominently displaying the sentence set forth in paragraph 1.E.1
with active links or immediate access to the full terms of the Project
Gutenberg™ License.
1.E.6. You may convert to and distribute this work in any binary,
compressed, marked up, nonproprietary or proprietary form,
including any word processing or hypertext form. However, if you
provide access to or distribute copies of a Project Gutenberg™ work
in a format other than “Plain Vanilla ASCII” or other format used in
the official version posted on the official Project Gutenberg™ website
(www.gutenberg.org), you must, at no additional cost, fee or
expense to the user, provide a copy, a means of exporting a copy, or
a means of obtaining a copy upon request, of the work in its original
“Plain Vanilla ASCII” or other form. Any alternate format must
include the full Project Gutenberg™ License as specified in
paragraph 1.E.1.
1.E.7. Do not charge a fee for access to, viewing, displaying,
performing, copying or distributing any Project Gutenberg™ works
unless you comply with paragraph 1.E.8 or 1.E.9.
1.E.8. You may charge a reasonable fee for copies of or providing
access to or distributing Project Gutenberg™ electronic works
provided that:
   • You pay a royalty fee of 20% of the gross profits you derive
    from the use of Project Gutenberg™ works calculated using the
    method you already use to calculate your applicable taxes. The
    fee is owed to the owner of the Project Gutenberg™ trademark,
    but he has agreed to donate royalties under this paragraph to
    the Project Gutenberg Literary Archive Foundation. Royalty
    payments must be paid within 60 days following each date on
    which you prepare (or are legally required to prepare) your
    periodic tax returns. Royalty payments should be clearly marked
    as such and sent to the Project Gutenberg Literary Archive
    Foundation at the address specified in Section 4, “Information
       about donations to the Project Gutenberg Literary Archive
       Foundation.”
   • You provide a full refund of any money paid by a user who
    notifies you in writing (or by e-mail) within 30 days of receipt
    that s/he does not agree to the terms of the full Project
    Gutenberg™ License. You must require such a user to return or
    destroy all copies of the works possessed in a physical medium
    and discontinue all use of and all access to other copies of
    Project Gutenberg™ works.
   • You provide, in accordance with paragraph 1.F.3, a full refund of
    any money paid for a work or a replacement copy, if a defect in
    the electronic work is discovered and reported to you within 90
    days of receipt of the work.
   • You comply with all other terms of this agreement for free
    distribution of Project Gutenberg™ works.
1.E.9. If you wish to charge a fee or distribute a Project Gutenberg™
electronic work or group of works on different terms than are set
forth in this agreement, you must obtain permission in writing from
the Project Gutenberg Literary Archive Foundation, the manager of
the Project Gutenberg™ trademark. Contact the Foundation as set
forth in Section 3 below.
1.F.
1.F.1. Project Gutenberg volunteers and employees expend
considerable effort to identify, do copyright research on, transcribe
and proofread works not protected by U.S. copyright law in creating
the Project Gutenberg™ collection. Despite these efforts, Project
Gutenberg™ electronic works, and the medium on which they may
be stored, may contain “Defects,” such as, but not limited to,
incomplete, inaccurate or corrupt data, transcription errors, a
copyright or other intellectual property infringement, a defective or
damaged disk or other medium, a computer virus, or computer
codes that damage or cannot be read by your equipment.
1.F.2. LIMITED WARRANTY, DISCLAIMER OF DAMAGES - Except for
the “Right of Replacement or Refund” described in paragraph 1.F.3,
the Project Gutenberg Literary Archive Foundation, the owner of the
Project Gutenberg™ trademark, and any other party distributing a
Project Gutenberg™ electronic work under this agreement, disclaim
all liability to you for damages, costs and expenses, including legal
fees. YOU AGREE THAT YOU HAVE NO REMEDIES FOR
NEGLIGENCE, STRICT LIABILITY, BREACH OF WARRANTY OR
BREACH OF CONTRACT EXCEPT THOSE PROVIDED IN PARAGRAPH
1.F.3. YOU AGREE THAT THE FOUNDATION, THE TRADEMARK
OWNER, AND ANY DISTRIBUTOR UNDER THIS AGREEMENT WILL
NOT BE LIABLE TO YOU FOR ACTUAL, DIRECT, INDIRECT,
CONSEQUENTIAL, PUNITIVE OR INCIDENTAL DAMAGES EVEN IF
YOU GIVE NOTICE OF THE POSSIBILITY OF SUCH DAMAGE.
1.F.3. LIMITED RIGHT OF REPLACEMENT OR REFUND - If you
discover a defect in this electronic work within 90 days of receiving
it, you can receive a refund of the money (if any) you paid for it by
sending a written explanation to the person you received the work
from. If you received the work on a physical medium, you must
return the medium with your written explanation. The person or
entity that provided you with the defective work may elect to provide
a replacement copy in lieu of a refund. If you received the work
electronically, the person or entity providing it to you may choose to
give you a second opportunity to receive the work electronically in
lieu of a refund. If the second copy is also defective, you may
demand a refund in writing without further opportunities to fix the
problem.
1.F.4. Except for the limited right of replacement or refund set forth
in paragraph 1.F.3, this work is provided to you ‘AS-IS’, WITH NO
OTHER WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED,
INCLUDING BUT NOT LIMITED TO WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR ANY PURPOSE.
1.F.5. Some states do not allow disclaimers of certain implied
warranties or the exclusion or limitation of certain types of damages.
If any disclaimer or limitation set forth in this agreement violates the
law of the state applicable to this agreement, the agreement shall be
interpreted to make the maximum disclaimer or limitation permitted
by the applicable state law. The invalidity or unenforceability of any
provision of this agreement shall not void the remaining provisions.
1.F.6. INDEMNITY - You agree to indemnify and hold the Foundation,
the trademark owner, any agent or employee of the Foundation,
anyone providing copies of Project Gutenberg™ electronic works in
accordance with this agreement, and any volunteers associated with
the production, promotion and distribution of Project Gutenberg™
electronic works, harmless from all liability, costs and expenses,
including legal fees, that arise directly or indirectly from any of the
following which you do or cause to occur: (a) distribution of this or
any Project Gutenberg™ work, (b) alteration, modification, or
additions or deletions to any Project Gutenberg™ work, and (c) any
Defect you cause.
      Section 2. Information about the Mission
      of Project Gutenberg™
Project Gutenberg™ is synonymous with the free distribution of
electronic works in formats readable by the widest variety of
computers including obsolete, old, middle-aged and new computers.
It exists because of the efforts of hundreds of volunteers and
donations from people in all walks of life.
Volunteers and financial support to provide volunteers with the
assistance they need are critical to reaching Project Gutenberg™’s
goals and ensuring that the Project Gutenberg™ collection will
remain freely available for generations to come. In 2001, the Project
Gutenberg Literary Archive Foundation was created to provide a
secure and permanent future for Project Gutenberg™ and future
generations. To learn more about the Project Gutenberg Literary
Archive Foundation and how your efforts and donations can help,
see Sections 3 and 4 and the Foundation information page at
www.gutenberg.org.
     Section 3. Information about the Project
     Gutenberg Literary Archive Foundation
The Project Gutenberg Literary Archive Foundation is a non-profit
501(c)(3) educational corporation organized under the laws of the
state of Mississippi and granted tax exempt status by the Internal
Revenue Service. The Foundation’s EIN or federal tax identification
number is 64-6221541. Contributions to the Project Gutenberg
Literary Archive Foundation are tax deductible to the full extent
permitted by U.S. federal laws and your state’s laws.
The Foundation’s business office is located at 809 North 1500 West,
Salt Lake City, UT 84116, (801) 596-1887. Email contact links and up
to date contact information can be found at the Foundation’s website
and official page at www.gutenberg.org/contact
     Section 4. Information about Donations to
     the Project Gutenberg Literary Archive
     Foundation
Project Gutenberg™ depends upon and cannot survive without
widespread public support and donations to carry out its mission of
increasing the number of public domain and licensed works that can
be freely distributed in machine-readable form accessible by the
widest array of equipment including outdated equipment. Many
small donations ($1 to $5,000) are particularly important to
maintaining tax exempt status with the IRS.
The Foundation is committed to complying with the laws regulating
charities and charitable donations in all 50 states of the United
States. Compliance requirements are not uniform and it takes a
considerable effort, much paperwork and many fees to meet and
keep up with these requirements. We do not solicit donations in
locations where we have not received written confirmation of
compliance. To SEND DONATIONS or determine the status of
compliance for any particular state visit www.gutenberg.org/donate.
While we cannot and do not solicit contributions from states where
we have not met the solicitation requirements, we know of no
prohibition against accepting unsolicited donations from donors in
such states who approach us with offers to donate.
International donations are gratefully accepted, but we cannot make
any statements concerning tax treatment of donations received from
outside the United States. U.S. laws alone swamp our small staff.
Please check the Project Gutenberg web pages for current donation
methods and addresses. Donations are accepted in a number of
other ways including checks, online payments and credit card
donations. To donate, please visit: www.gutenberg.org/donate.
     Section 5. General Information About
     Project Gutenberg™ electronic works
Professor Michael S. Hart was the originator of the Project
Gutenberg™ concept of a library of electronic works that could be
freely shared with anyone. For forty years, he produced and
distributed Project Gutenberg™ eBooks with only a loose network of
volunteer support.
Project Gutenberg™ eBooks are often created from several printed
editions, all of which are confirmed as not protected by copyright in
the U.S. unless a copyright notice is included. Thus, we do not
necessarily keep eBooks in compliance with any particular paper
edition.
Most people start at our website which has the main PG search
facility: www.gutenberg.org.
This website includes information about Project Gutenberg™,
including how to make donations to the Project Gutenberg Literary
Archive Foundation, how to help produce our new eBooks, and how
to subscribe to our email newsletter to hear about new eBooks.
back
back
Welcome to our website – the ideal destination for book lovers and
knowledge seekers. With a mission to inspire endlessly, we offer a
vast collection of books, ranging from classic literary works to
specialized publications, self-development books, and children's
literature. Each book is a new journey of discovery, expanding
knowledge and enriching the soul of the reade
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
Let us accompany you on the journey of exploring knowledge and
personal growth!
                        textbookfull.com